Webinars

TRALI Mitigation Webinar

February 23, 2016   08:00:00 a.m. - 09:30:00 a.m.  PST

Online
United States
English

Register Online »

Are you preparing for the implementation of AABB standard 5.4.1.2 for TRALI mitigation? 

Learn how LABScreen® Multi, the only FDA cleared, IVD test for the simultaneous detection of HLA Class I, Class II and HNA-3a antibodies, can be part of a comprehensive TRALI mitigation strategy.

FEATURED PRESENTATION
 

Evaluation of the Microbeads Assay LABScreen Multi for Granuloycte Antibody Detection to Improve the Prevention of TRALI.

Undine Schulz, PhD.

Director, HLA Laboratory | German Red Cross Blood Donor Service North-East